Improve vision in legally blind dry AMD
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial studies a vision treatment approach for people age 50+ who have dry age-related macular degeneration (AMD) and are legally blind from it. It aims to see whether the treatment can improve vision-related outcomes in the study eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 50 years old
- You have dry AMD in the study eye
- Your corrected vision in the study eye is very poor (legally blind from AMD)
- Your cornea (the clear front of the eye) looks normal on a special scan
- You do not wear contact lenses
- You can follow all study visits and sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes how dry age-related macular degeneration (AMD) changes over time using regular eye exams. It may help doctors better understand the natural pattern of progression and which patients are more likely to worsen.
This study tests a light-based treatment (photobiomodulation) for dry AMD, using the Valeda Light Delivery System. It may help improve vision and eye health over time.
This trial tests an experimental gene therapy, OCU410, for people with geographic atrophy, an advanced form of dry AMD that causes blind spots in the center of vision. The study aims to see if this treatment can slow down the progression of the disease and help preserve remaining vision.
This trial tests a new approach to improve vision in people with end-stage age-related macular degeneration (AMD). It aims to help those whose vision has dropped to a moderate or severe level, even with glasses, and who are not contact lens wearers.
This trial tests whether visual rehabilitation can help improve both vision and mood in people with advanced dry age-related macular degeneration. It aims to understand the link between vision loss and depression.
This trial tests if repeated low-level red-light therapy can help people with dry age-related macular degeneration (AMD), a condition that causes gradual vision loss. The therapy uses red light to potentially slow or improve vision problems.
Hear when a new Dry Age-related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.